Dr. Surbhi Sidana specializes in the treatment of plasma cell disorders, such as multiple myeloma, amyloidosis and related disorders. Her research focuses on the development of novel therapeutic approaches, biomarkers and management of treatment toxicity in this field. Dr. Sidana's expertise includes blood and marrow transplantation and CAR-T cell therapy.